ivabradine

FDA Drug Profile — Corlanor, ivabradine

ivabradine is listed in the FDA National Drug Code directory with 12 NDC codes, marketed under brand names including Corlanor, ivabradine. Available dosage forms: solution, tablet, tablet, film coated.

Drug details

Generic Name
ivabradine
Brand Names
Corlanor, ivabradine
Application Number
NDA209964
Sponsor
Amgen Inc
NDC Codes
12
Dosage Forms
SOLUTION, TABLET, TABLET, FILM COATED
Routes
ORAL
Active Ingredients
IVABRADINE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Ivabradine tablets are a hyperpolarization-activated cyclic nucleotide-gated channel blocker indicated: To reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with reduced left ventricular ejection fraction. ( 1.1 ) 1.1 Heart Failure in Adult Patients Ivabradine tablets are indicated to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with left ventricular ejection fraction ≤ 35%, who are in sinus rhythm with resting heart rate ≥ 70 beats per minute and either are on maximally tolerated doses of beta-blockers or have a contraindication to beta-blocker use.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.